Your browser doesn't support javascript.
loading
Linking Angelman and dup15q data for expanded research (LADDER) database: a model for advancing research, clinical guidance, and therapeutic development for rare conditions.
Potter, Sarah Nelson; Reynolds, Elizabeth; Okoniewski, Katherine C; Edwards, Anne; Gable, Julia; Hill, Christine; Bakalov, Vesselina; Zentz, Stephanie; Whiting, Carolyne; Cheves, Emily; Garbarini, Katie; Jalazo, Elizabeth; Howell, Carrie; Moore, Amanda; Wheeler, Anne.
Afiliação
  • Potter SN; RTI International, 3040 E. Cornwallis Road, Research Triangle Park, NC 27709-2194, USA.
  • Reynolds E; RTI International, Research Triangle Park, NC, USA.
  • Okoniewski KC; RTI International, Research Triangle Park, NC, USA.
  • Edwards A; RTI International, Research Triangle Park, NC, USA.
  • Gable J; RTI International, Research Triangle Park, NC, USA.
  • Hill C; RTI International, Research Triangle Park, NC, USA.
  • Bakalov V; RTI International, Research Triangle Park, NC, USA.
  • Zentz S; RTI International, Research Triangle Park, NC, USA.
  • Whiting C; RTI International, Research Triangle Park, NC, USA.
  • Cheves E; RTI International, Research Triangle Park, NC, USA.
  • Garbarini K; Angelman Syndrome Foundation, Aurora, IL, USA.
  • Jalazo E; Dup15q Alliance, Matthews, NC, USA.
  • Howell C; Department of Pediatrics, The University of North Carolina School of Medicine, Chapel Hill, NC, USA.
  • Moore A; Dup15q Alliance, Matthews, NC, USA.
  • Wheeler A; Angelman Syndrome Foundation, Aurora, IL, USA.
Ther Adv Rare Dis ; 5: 26330040241254122, 2024.
Article em En | MEDLINE | ID: mdl-38808315
ABSTRACT
Angelman syndrome (AS) and duplication 15q (dup15q) syndrome are rare neurogenetic conditions arising from a common locus on the long arm of chromosome 15. Individuals with both conditions share some clinical features (e.g. intellectual disability, epilepsy) and often require lifelong care. Disease-modifying therapies for both conditions are emerging, resulting in a significant need for a better understanding of the natural history of both AS and dup15q. Patient advocacy groups for both conditions recognized a need for a data repository that would link data on individuals from multiple sources to expand research, increase understanding of natural history, and accelerate the development of treatments, resulting in the Linking Angelman and Dup15q Data for Expanded Research (LADDER) Database. This paper describes the development and functionality of the LADDER Database - including challenges, lessons learned, and preliminary feasibility - and how it can be used as a model for other rare conditions.
The LADDER database a model for advancing research, clinical guidance, and therapeutic development for rare conditions This paper describes the development and functionality of the Linking Angelman and Dup15q Data for Expanded Research (LADDER) Database, which is a data repository for two rare neurogenetic conditions Angelman syndrome (AS) and duplication 15q (dup15q) syndrome. AS and dup15q syndrome arise from genetic abnormalities on chromosome 15 and share some clinical features (e.g. intellectual disability, epilepsy). LADDER was developed by patient advocacy organizations representing each condition in partnership with RTI International. LADDER links data on individuals from multiple sources to expand research, increase understanding of natural history, and accelerate the development of treatments for both AS and dup15q syndrome. The LADDER Database can be used as a model for expanding research and enhancing clinical trial readiness in other rare conditions.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos